Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
about
Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the LiteratureThe positive immunostaining of TMPRSS2-ERG is not associated with unfavourable outcomes and biochemical recurrence after radical prostatectomy in Turkish patients
P2860
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@en
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@nl
type
label
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@en
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@nl
altLabel
Prostate Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
@en
prefLabel
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@en
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@nl
P2093
P2860
P50
P1476
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
@en
P2093
Elin Ersvær
Håvard E Danielsen
João D Barros-Silva
Manohar Pradhan
Tarjei Sveinsgjerd Hveem
Wanja Kildal
P2860
P304
P356
10.1016/J.TRANON.2016.08.005
P407
P577
2016-12-01T00:00:00Z